STEM Review Turks & Caicos: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Review Turks & Caicos.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 8, 2025

December 8, 2025

1 billion financing empowers! EngineAI T800 comes out in a big way, accelerating industrialization process

GlobeNewswire

December 8, 2025

REKT Announces Launch of the First Meme Token That Rewards Losing Trades

GlobeNewswire

December 8, 2025

Kraig Biocraft Laboratories Secures Usage Rights to Strategic Government-Owned Mulberry Gardens to Support Major Spider Silk Production Expansion

GlobeNewswire

December 8, 2025

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

GlobeNewswire

December 8, 2025

The Acceleration Continues: Vetty Named One of Nucleus Research’s Hot Companies to Watch in 2026

GlobeNewswire

December 8, 2025

Mercury Showcases Expanding Portfolio of Electronic Warfare Capabilities at AOC 2025

GlobeNewswire

December 8, 2025

Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting

GlobeNewswire

December 8, 2025

Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis

GlobeNewswire

December 8, 2025

Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia

GlobeNewswire

December 8, 2025

Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference

GlobeNewswire

December 8, 2025

Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026

GlobeNewswire

December 8, 2025

Ocular Therapeutix™ Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI™ in Wet AMD

GlobeNewswire

December 8, 2025

Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

GlobeNewswire

December 8, 2025

Aurora Mobile’s EngageLab Launches AI-Powered Customer Service Platform LiveDesk, Revolutionizing Enterprise Customer Experience

GlobeNewswire

December 8, 2025

RentRedi Launches Spanish-Language Version of Tenant App, Plus Spanish Support, to Strengthen Landlord-Tenant Communication

GlobeNewswire

December 8, 2025

Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum

GlobeNewswire

December 8, 2025

Castellum Announces the Award of Multiple Missile Defense Agency SHIELD IDIQ Contracts

GlobeNewswire

December 8, 2025

Dyne Therapeutics Announces Positive Topline Results from Phase 1/2 DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

GlobeNewswire

December 8, 2025

MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

GlobeNewswire

December 8, 2025

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

GlobeNewswire